Immunonutrition support during cancer treatment
Part of Cancer, Lungs & breathing clinical trials.
This study tests whether special nutritional support (called immunonutrition) helps patients with head and neck, lung, or rectal cancer who are receiving chemotherapy, radiation, or immunotherapy. The goal is to see if it improves how well treatment works and how you feel during and after cancer care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with head and neck cancer, lung cancer, or rectal cancer that your doctor plans to treat with chemotherapy, radiation, immunotherapy, or a combination
- You are age 18 or older
- Your overall health and ability to do daily activities is reasonably good (ECOG score less than 2, meaning you can care for yourself and do light activities)
- Your kidneys, liver, and bone marrow are working well enough (confirmed by blood tests)
- You are fully recovered from any recent surgery before starting cancer treatment
- You are not currently using tube feeding or IV nutrition at home
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether adding special nutrition support (“immunonutrition”) can help people with head-and-neck cancer tolerate treatment with chemoradiotherapy, and possibly improve comfort and treatment completion. You may be eligible if you are starting or will have curative or extra (adjuvant) chemoradiotherapy and can complete study measurements.
This trial studies whether adding special nutrition (oral immunonutrition supplements) can help immunotherapy work better in people with metastatic non-small cell lung cancer. Participants receive immunotherapy, with or without chemotherapy, and must be able to take oral supplements.
This study tests whether a special nutrition plan (immunonutrition) helps people with advanced cervical cancer who are having chemoradiation. It is for those who are also malnourished.
This trial studies whether adding an “immunonutrition” nutrition plan to standard chemoradiation can improve outcomes for people with locally advanced, unresectable esophageal squamous cell cancer. It may help the treatment work better by supporting the immune system during therapy.
This trial looks at how your nutrition status affects the success of immunotherapy drugs in people with advanced esophageal squamous cell cancer or stomach adenocarcinoma that has spread. It aims to find if better nutrition leads to better treatment results.
This trial tests a special nutritional drink (oral immunonutrition) to see if it can reduce side effects from chemotherapy and radiation in people with pancreatic cancer. It may help you feel better during treatment if you are at risk for malnutrition.
Hear when a new Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.